MYOK insider filings

MyoKardia, Inc. — 13 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-11-19. Screen MYOK transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MYOK between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — MyoKardia, Inc.

FiledFormInsiderReported transactionsSource
2020-11-194Harris Taylor C. — Chief Financial OfficerCode (U): 42,559 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 49,400 (derivative) · Disposition to issuer (D): 46,060 (derivative)EDGAR
2020-11-194AGARWAL SUNIL — DirectorCode (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · +1 moreEDGAR
2020-11-194Fairey William — EVP, Chief Commercial OfficerCode (U): 42,199 · Disposition to issuer (D): 69,500 (derivative) · Disposition to issuer (D): 39,022 (derivative)EDGAR
2020-11-194Bauer Jake — Chief Business OfficerCode (U): 90,209 · Disposition to issuer (D): 16,530 (derivative) · Disposition to issuer (D): 8,748 (derivative) · Disposition to issuer (D): 35,150 (derivative) · Disposition to issuer (D): 57,400 (derivative) · Disposition to issuer (D): 34,000 (derivative) · +1 moreEDGAR
2020-11-194Waynick Denelle J — Chief Legal OfficerCode (U): 25,000 · Disposition to issuer (D): 80,000 (derivative)EDGAR
2020-11-194GIANAKAKOS ANASTASIOS — President and CEO, DirectorCode (U): 141,405 · Code (U): 129,407 · Code (U): 300,000 · Code (U): 7,000 · Code (U): 10,000 · Code (U): 53,087 · +8 moreEDGAR
2020-11-194McDowell Robert Scott — Chief Scientific OfficerCode (U): 36,616 · Disposition to issuer (D): 87,074 (derivative) · Disposition to issuer (D): 40,816 (derivative) · Disposition to issuer (D): 36,735 (derivative) · Disposition to issuer (D): 27,211 (derivative) · Disposition to issuer (D): 79,850 (derivative) · +4 moreEDGAR
2020-11-194Meeker David P — DirectorCode (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR
2020-11-194Popovits Kimberly J — DirectorCode (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR
2020-11-194PERRY MARK L — DirectorCode (U): 29,508 · Disposition to issuer (D): 21,800 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · +1 moreEDGAR
2020-11-194YARNO WENDY L — DirectorCode (U): 5,508 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR
2020-11-194CRANSTON MARY B — DirectorCode (U): 4,100 · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR
2020-10-304/ACRANSTON MARY B — DirectorOption exercise (M): 371 @ $11.69 · Sale (S): 371 @ $98.68 · Option exercise (M): 21,629 @ $11.69 · Sale (S): 300 @ $97.25 · Sale (S): 21,329 @ $96.59EDGAR

Recent 8-K events — MyoKardia, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2020-11-178-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2020-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2020-10-058-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MYOK returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs